Sign In
Buy SMTI
$33.86
-0.200 (-0.587%)
At Close: Jul 31, 2026
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
07:30am, Wednesday, 01'st Oct 2025
FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing trans
Sanara MedTech: Growth Remains Strong As Debt Concerns Recede
02:46pm, Thursday, 04'th Sep 2025
SMTI's Surgical segment revenue grew 28% year-over-year in Q1 to $25.8 million. Surgical segment adjusted EBITDA was $4.7 million, while THP correspondingly posted a loss of $2.1 million. Management i
Sanara MedTech Inc. Announces Chief Executive Officer Transition
04:30pm, Tuesday, 02'nd Sep 2025
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
04:05pm, Wednesday, 27'th Aug 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on develop
Sanara MedTech Inc. (SMTI) Q2 2025 Earnings Call Transcript
12:18pm, Wednesday, 13'th Aug 2025
Sanara MedTech Inc. (NASDAQ:SMTI ) Q2 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Elizabeth B. Taylor - Chief Financial Officer Ronald T.
Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates
09:26am, Wednesday, 13'th Aug 2025
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.41 per share a year ago.
Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)
07:00am, Wednesday, 13'th Aug 2025
Net Revenue Increased 28% Year-Over-Year in Q2; Increased 27% Year-Over-Year in First Six Months of 2025 Announces Process to Evaluate Strategic Alternatives for its Tissue Health Plus, LLC Subsidia
Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
04:05pm, Tuesday, 15'th Jul 2025
FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing trans
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
04:05pm, Monday, 14'th Jul 2025
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus' technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “
Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb
06:22am, Monday, 09'th Jun 2025
Sanara MedTech's surgical revenue grew 26% year-over-year in Q1, with a gross margin of 92%. Surgical adjusted EBITDA was $2.7 million in Q1, while THP correspondingly posted a loss of $2 million. Hig
Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript
11:55am, Wednesday, 14'th May 2025
Sanara MedTech Inc. (NASDAQ:SMTI ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman, Chief Executive Officer Seth Yon - President, Chief Com
Sanara MedTech Inc. (SMTI) Reports Q1 Loss, Tops Revenue Estimates
09:51am, Wednesday, 14'th May 2025
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.21 per share a year ago.
Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)
07:00am, Wednesday, 14'th May 2025
Q1 Net Revenue Increased 26% Year-Over-Year FORT WORTH, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a me
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025
08:00am, Wednesday, 23'rd Apr 2025
FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing tran
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
04:00pm, Thursday, 10'th Apr 2025
FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on develo
